The Oceania Times

Top Menu

  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

Main Menu

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions

logo

The Oceania Times

  • Australian Economy
  • Brokers
  • Commodities
  • Currencies
  • Financial Market
  • Gold and Precious Metals
  • Investment
  • Stock Shares
  • gold price: Gold likely to consolidate ahead of the US FOMC decision

  • Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

  • Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

  • China to boost economic rebound, stabilize foreign trade, investment

Stock Shares
Home›Stock Shares›FTSE 100 and FTSE 250 shares – what to expect on the stock market next week

FTSE 100 and FTSE 250 shares – what to expect on the stock market next week

By Megan
May 27, 2022
54
0
Share:

Among those currently scheduled to release results next week:

  • B&M European Value Retail could outline how inflation is affecting its core customers
  • Trading patterns in America will be in-focus for Dr Martens
  • We’d like to know if Pennon will reveal how much inflation’s driven interest payments higher

If you’d like to receive weekly shares content from us, sign up to our share insight email.

Among those currently scheduled to release results next week:








30-May
No FTSE 350 Reporters








02-Jun
No FTSE 350 Reporters








03-Jun
No FTSE 350 Reporters

*Events on which we will be updating investors. We don’t provide a view on B&M and Dr Martens.

Pennon – Laura Hoy, Equity Analyst

Debt will be in focus as Pennon spells out its full year progress. The group stretched its balance sheet to acquire Bristol Water. In normal times this may not be more than a bugbear, but given that some 26% of Pennon’s debt is index-linked, it’s something to keep a close eye on. For every 1% inflation rises, Pennon’s on the hook for an extra £8m in finance costs. That’s likely to have been adding up this year considering inflation’s risen 7.8% at last check. We’d like to hear how management intends to keep these ballooning costs under control.

Part of that will be evaluating how the Bristol Water deal is progressing. Last we heard management was expecting the deal to yield roughly £20m in annual cost savings by 2024/2025. That would more than offset near-term inflationary pain, but getting there smoothly remains a challenge.

That brings us to shareholder returns, which tend to be a main draw for utilities like Pennon. Demands on cash aren’t insignificant at the moment, so shareholder return plans will be closely followed.

See the Pennon share price, charts and our latest view

Sign up to Pennon research

B&M European Value Retail – Sophie Lund-Yates, Equity Analyst

The market hasn’t reacted kindly to news B&M’s CEO is stepping down. While a changing of the guard can cause markets to wobble at the best of times, some of the negative sentiment stems from nervousness around B&M’s path from here.

One of the biggest things to watch next week will be the outlook statement. B&M’s core customers are likely among the worst affected by inflation. The group’s lower prices are also not as competitive as they once were, according to analysts. That means it’s less likely to capture more affluent customers looking for value options, too.

The market is expecting operating profits of around £578m, which would be a 5.8% fall on last year. This doesn’t seem an unreasonable expectation, and we think the biggest question from investors will be what happens next.

See the B&M share price and charts

Dr Martens – Sophie Lund-Yates, Equity Analyst

In the third quarter the famous shoe brand saw revenue rise 15%, ignoring the effect of exchange rates. That bodes well for expectations of 17.4% growth for the full year, although please remember nothing is guaranteed.

The group has been held back by weaker trading in Asia Pacific because of Covid. This has caused a particular problem in third party stores, with Australia and China being the worst affected. While this isn’t something the group can control, we’re interested to see how the situation has evolved given lockdowns in China.

We’ll also have an eye on growth in America. The 6% increase in the third quarter was weaker than they would have liked. This was partly caused by shipping delays, but a longer run of disappointing growth could suggest the brand is losing its potency.

See the Dr Martens share price and charts

Unless otherwise stated estimates are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Past performance is not a guide to the future. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.

Share insight: our weekly email

Sign up to receive weekly shares content from HL

Please correct the following errors before you continue:

What did you think of this article?

Source link

Previous Article

Indian fintech Jar eyes $50 million investment ...

Next Article

Pacifico Airports: With Fantastic Results, Shares Should ...

0
Shares
  • 0
  • +
  • 0
  • 0
  • 0
  • 0

Megan

Related articles More from author

  • Stock Shares

    How Brainchip shares gained 63% in a year when tech stocks nosedived

    July 4, 2022
    By Megan
  • Stock Shares

    Carnival Shares Plunge Nearly 15% As Morgan Stanley Warns Of Potential Stock Wipeout

    June 29, 2022
    By Megan
  • Stock Shares

    3 Excellent Dividend Stocks to Add to Your Holiday Shopping List

    November 26, 2022
    By Megan
  • Stock Shares

    Pinterest CEO Ben Silbermann is stepping down and the stock is up

    June 28, 2022
    By Megan
  • Stock Shares

    10 Best Low-Volatility Stocks to Buy Now

    July 25, 2022
    By Megan
  • Stock Shares

    Noble Corporation plc announces changes to its share capital

    November 26, 2022
    By Megan

Leave a reply Cancel reply

You may interested

  • Australian Economy

    Australia should reach net zero by 2040, new Climate Change Authority member says | Climate crisis

  • Brokers

    Wedbush Brokers Cut Earnings Estimates for Silvergate Capital Co. (NYSE:SI)

  • Brokers

    New York State Teachers Retirement System Grows Stake in Interactive Brokers Group, Inc. (NASDAQ:IBKR)

  • LATEST REVIEWS

  • TOP REVIEWS

Timeline

  • January 29, 2023

    gold price: Gold likely to consolidate ahead of the US FOMC decision

  • January 29, 2023

    Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

  • January 29, 2023

    Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

  • January 29, 2023

    Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

  • January 29, 2023

    China to boost economic rebound, stabilize foreign trade, investment

Best Reviews

Latest News

Gold and Precious Metals

gold price: Gold likely to consolidate ahead of the US FOMC decision

Spot gold closed with a gain of nearly 0.1% in the week ending January 27. With US Q4 advance GDP, durable goods orders, weekly jobless claims, pending home sales, and ...
  • Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

    By Megan
    January 29, 2023
  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    By Megan
    January 29, 2023
  • Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

    By Megan
    January 29, 2023
  • China to boost economic rebound, stabilize foreign trade, investment

    By Megan
    January 29, 2023
  • Recent

  • Popular

  • Comments

  • gold price: Gold likely to consolidate ahead of the US FOMC decision

    By Megan
    January 29, 2023
  • Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

    By Megan
    January 29, 2023
  • Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    By Megan
    January 29, 2023
  • Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

    By Megan
    January 29, 2023
  • gold price: Gold likely to consolidate ahead of the US FOMC decision

    By Megan
    January 29, 2023
  • Australia’s economy: boom or bust?

    By Megan
    September 9, 2019
  • Australian economy suffers virus symptoms

    By Megan
    February 10, 2020
  • Australian economy likely already slowing in Q2 before Delta downturn

    By Megan
    August 30, 2021

Trending News

  • Gold and Precious Metals

    gold price: Gold likely to consolidate ahead of the US FOMC decision

    Spot gold closed with a gain of nearly 0.1% in the week ending January 27. With US Q4 advance GDP, durable goods orders, weekly jobless claims, pending home sales, and ...
  • Stock Shares

    Raymond James & Associates sells 2,165 Masonite International Co. shares (NYSE:DOOR)

    The most recent report that Raymond James & Associates submitted to the Securities and Exchange Commission indicates that the investment firm liquidated a portion of its holdings in Masonite International ...
  • Stock Shares

    Raymond James & Associates has purchased shares of NGM Biopharmaceuticals, Inc. (NASDAQ:NGM).

    Raymond James & Associates disclosed in its most recent 13F filing with the Securities and Exchange Commission that it increased its holdings in N.G.M. Biopharmaceuticals, Inc. (NASDAQ: N.G.M.) during the ...
  • Gold and Precious Metals

    Raymond James & Associates buys 175,632 Sandstorm Gold Ltd. shares (NYSE:SAND)

    According to the most recent filing that Raymond James & Associates made with the Securities and Exchange Commission, the investment firm increased its holdings in Sandstorm Gold Ltd. (NYSE: SAND) ...
  • Investment

    China to boost economic rebound, stabilize foreign trade, investment

    China will consolidate and expand the momentum of its economic rebound, accelerate consumption recovery and stabilize foreign trade and investment, according to the decisions made at the State Council executive ...
  • About us
  • Contact Us
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms and Conditions
© Copyright The Oceania Times. All rights reserved.

SUBSCRIBE TO OUR NEWSLETTER

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.